GenMark Seeks to Raise at Least $30M

6/20/11Follow @bvbigelow

GenMark Diagnostics (NASDAQ: GNMK), a Carlsbad, CA, maker of automated DNA and RNA diagnostics testing systems, said it plans to raise at least $30 million through a secondary offering of its stock to the public at a price of $4.25 per share. The offering, which is expected to close Wednesday, consists of more than 7 million GenMark shares, with an additional 1 million shares available as an option to cover over-allotments.

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at or call (619) 669-8788 Follow @bvbigelow

By posting a comment, you agree to our terms and conditions.